Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02663518 · OUTCOME

Part 4: Overall Response Rate (ORR) in Cutaneous T-Cell Lymphoma (CTCL) Both Fungoides and Sezary Syndrome

A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors · Source last updated 2024-05-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
From first dose of study till the progressive disease/death or withdrawal (maximum observation 6 years 10 months)

What was measured

ORR is presented in this outcome measure as number of responders.

Analysis population: Data for this outcome measure is not available as analysis was not performed because: 1) due to futility and heterogenicity of respective data of the parameters of organ system (i.e., skin, blood, lymph node, and viscera; 2) the Olsen 2011 criteria already defined the "Global Response Score" to determine the Global Response (GR) consisting of the 4 components which (GR) was more important assessment affecting overall prognosis.

Groups in this outcome

Part 4: CTCL

Participants with CTCL who received study drug in part 4.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Part 4: CTCL0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
ORR is presented in this outcome measure as number of responders.
groups
  1. description
    Participants with CTCL who received study drug in part 4.
    id
    OG000
    title
    Part 4: CTCL
population Description
Data for this outcome measure is not available as analysis was not performed because: 1) due to futility and heterogenicity of respective data of the parameters of organ system (i.e., skin, blood, lymph node, and viscera; 2) the Olsen 2011 criteria already defined the "Global Response Score" to determine the Global Response (GR) consisting of the 4 components which (GR) was more important assessment affecting overall prognosis.
reporting Status
POSTED
time Frame
From first dose of study till the progressive disease/death or withdrawal (maximum observation 6 years 10 months)
title
Part 4: Overall Response Rate (ORR) in Cutaneous T-Cell Lymphoma (CTCL) Both Fungoides and Sezary Syndrome
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice